logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Xanthinol Nicotinate CAS 437-74-1 API Active Pharmaceutical Ingredient

Xanthinol Nicotinate CAS 437-74-1 API Active Pharmaceutical Ingredient

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 437-74-1

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:

api active pharmaceutical ingredient

,

Xanthinol Nicotinate CAS 437-74-1

CAS NO::
437-74-1
Appearance::
White Crystalline Powder
Molecular Formula::
C19H26N6O6
Molecular Weight::
434.44600
EINECS NO::
207-115-7
MDL NO::
MFCD00058342
CAS NO::
437-74-1
Appearance::
White Crystalline Powder
Molecular Formula::
C19H26N6O6
Molecular Weight::
434.44600
EINECS NO::
207-115-7
MDL NO::
MFCD00058342
Xanthinol Nicotinate CAS 437-74-1 API Active Pharmaceutical Ingredient

Product Description:

Product Name: Xanthinol Nicotinate CAS NO: 437-74-1

 

 

Synonyms:

icotinicacid;

Xanthinolnicotinat;

7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethylpurine-2,6-dione,pyridine-3-carboxylic acid;

 

 

Chemical & Physical Properties:

Appearance: White crystalline powder

Assay :≥99%

Boiling Point: 589.3℃ at 760 mmHg

Melting Point: 180-184℃

Flash Point: 310.2℃

Vapor Pressure: 9.89E-15mmHg at 25℃

Stability: Stable at normal temperatures and pressures

 

 

Safety Information:

HS Code: 2933990090

WGK Germany: 2

RTECS: QT1500000

 

 

Nicotinic acid of tenofovir is suitable for the treatment of cerebrovascular disorder (such as cerebral thrombosis, cerebral embolism sequela, brain surgery, brain trauma sequela, stroke sequela, carotid artery obstruction caused by hypoxic cerebral bate disease, senile cerebral dysfunction, etc.), coronary heart disease, division, (prevention of recurrence) after myocardial infarction and myocarditis, migraine headaches, ear disease between vertigo, raynaud's disease, Claudication, diabetic gangrene, thrombophlebitis, varicose veins, Chemicalbook selection, pulmonary embolism, bedsore, chilblain, and hyperlipidemia. Usage and Dosage: Oral: 0.1 ~ 0.2g each time, 3 times a day, after meals. IV drip: 300mg on day 1; 600mg daily on days 2 to 6; 900mg daily on days 7-14, dissolved in 500ml 10% glucose solution. 35 pieces for a course of treatment. Aderse Reactions and Cautions: Occasionally dry mouth, flushing face, lip numbness, chest tightness, rash, itchy skin, etc.

7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethylpurine-2,6-dione,pyridine-3-carboxylic acid is suitable for ischemic cerebrovascular diseases such as cerebral thrombosis and sequelae of stroke. Xanthinolnicotinat is suitable for vasodilator, used for brain dysfunction, cerebral thrombosis and other cerebrovascular diseases.

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.